HCA Healthcare is lowering its full-year 2026 guidance after surgical volumes declined in the second quarter. Same-facility inpatient surgeries fell 2.3% and outpatient surgeries dropped 3.4% compared with the prior-year period, the company said. The service mix shift compounds the payer mix challenges HCA faces from rising uninsured patients. The company now expects 2026 revenues of $77 billion to $79.5 billion, narrowing from a prior range of $76.5 billion to $80 billion. Adjusted Ebitda guidance moved to $15.4 billion to $16.1 billion, down from $15.55 billion to $16.45 billion.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
(END) Dow Jones Newswires
July 14, 2026 08:45 ET (12:45 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.